Remove Academic Remove Biomarkers Remove Heart Failure
article thumbnail

ACE Inhibitor Not Protective Against Heart Damage from Chemotherapy

DAIC

The PROACT study reported no impact on cardiotoxicity biomarkers or secondary endpoints related to heart function among patients who took high doses of enalapril, an ACE inhibitor, along with high doses of anthracyclines.

article thumbnail

COVID-19 myocarditis illusions

Dr. Anish Koka

So imagine my surprise when I saw peer reviewed research based on a cardiac MRI study come out in 2020 suggesting that 78% of patients who survived COVID may have significant heart damage. The article and authors were more suited as writers for Oprah and Dr. Phil than a well respected academic journal. I have no idea.

article thumbnail

Championing Change: Celebrating Cardiometabolic Health Congress (CMHC) Women Faculty

Cardiometabolic Health Congress

Her research focuses on women’s cardiovascular health and cardio-obstetrics, cardiovascular risk prediction using coronary artery calcium scores and biomarkers, lipids, and cardiometabolic diseases. A framework for mentor-mentees can help promote and retain women in academic medicine.

article thumbnail

The legal case – naming a few names

Dr. Malcolm Kendrick

At one point George Mann attempted to arrange a meeting of scientists who agreed that the diet-heart/cholesterol hypothesis was bunk. I believe you are right, and that the diet-heart hypothesis is wrong, but I cannot join you, for that would jeopardize my perks and funding. SEARCH trial of simvastatin dose (1997-2010) Merck: £22.7M